PharmaEngine, Inc. (TPEX:4162)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.10
+1.10 (1.86%)
Aug 26, 2026, 1:30 PM CST

PharmaEngine Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1771,584993.7875.621,7692,151
Short-Term Investments
3,8953,1332,8672,7521,8371,663
Trading Asset Securities
----55.59-
Cash & Short-Term Investments
5,0724,7173,8613,6283,6613,814
Cash Growth
-6.12%22.17%6.42%-0.91%-4.00%12.37%
Accounts Receivable
217.47262.441,844174.17160.34160.48
Other Receivables
3054.2587.5997.4163.5122.83
Receivables
247.47316.691,932271.58223.85183.31
Inventory
37.939.8728.3815.934.385.43
Prepaid Expenses
8.9311.466.47.486.576.48
Other Current Assets
-----0.08
Total Current Assets
5,3665,0855,8273,9233,9264,009
Property, Plant & Equipment
39.7344.6810.2418.0325.927.89
Other Intangible Assets
0.81.11.781.882.510.6
Long-Term Deferred Tax Assets
13.0814.365.9189.544.98
Other Long-Term Assets
2.532.532.442.982.53.9
Total Assets
5,4225,1485,8483,9543,9674,026

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
33.6435.58----
Accrued Expenses
-100.1399.3167.2261.3164.14
Current Portion of Leases
8.68.667.147.677.547.59
Current Income Taxes Payable
25.6830.11327.9--6.92
Other Current Liabilities
410.9812.678.78.989.99.06
Total Current Liabilities
478.89187.15443.0583.8678.7487.71
Long-Term Leases
29.1833.46-7.1414.81-
Long-Term Deferred Tax Liabilities
4.180.994.96-0.92-
Total Liabilities
512.25221.59448.0191.0194.4787.71

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,4571,4571,4571,4571,4571,466
Additional Paid-In Capital
1,6161,6161,6161,6161,6171,620
Retained Earnings
1,9711,9872,461925.31937.851,101
Treasury Stock
-133.41-133.41-133.41-133.41-133.41-248.24
Comprehensive Income & Other
---0.41-1.79-5.97-
Shareholders' Equity
4,9104,9265,4003,8633,8723,939
Total Liabilities & Equity
5,4225,1485,8483,9543,9674,026

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
37.7842.127.1414.8122.357.59
Net Cash (Debt)
5,0344,6753,8543,6133,6393,806
Net Cash Growth
-6.73%21.30%6.65%-0.71%-4.39%12.88%
Net Cash Per Share
34.9732.4826.7825.1425.3226.30
Filing Date Shares Outstanding
144.12143.68143.68143.68143.69143.6
Total Common Shares Outstanding
144.12143.68143.68143.68143.69143.6
Working Capital
4,8874,8985,3843,8393,8473,921
Book Value Per Share
34.0734.2837.5826.8926.9527.43
Tangible Book Value
4,9094,9255,3983,8613,8703,938
Tangible Book Value Per Share
34.0634.2837.5726.8726.9327.42
Machinery
-5.475.184.444.030.8
Leasehold Improvements
---7.697.697.69